dc.creatorGonzález, Sergio [Univ Mayor, Escuela Odontol, Santiago, Chile]
dc.creatorJoséBarrera, Maria
dc.creatorAguilera, Sergio
dc.creatorCarvajal, Patricia
dc.creatorCastro, Isabel
dc.creatorMolina, Claudio
dc.creatorMatus, Soledad
dc.creatorJara, Daniela
dc.creatorJulieta González, Maria
dc.date.accessioned2020-04-12T14:11:55Z
dc.date.accessioned2020-04-14T15:37:54Z
dc.date.accessioned2022-10-18T18:41:35Z
dc.date.available2020-04-12T14:11:55Z
dc.date.available2020-04-14T15:37:54Z
dc.date.available2022-10-18T18:41:35Z
dc.date.created2020-04-12T14:11:55Z
dc.date.created2020-04-14T15:37:54Z
dc.date.issued2019
dc.identifierBarrera M, Aguilera S, Carvajal P, Castro I, González S, Molina C, Matus S, Jara D, González M. Tofacitinib Inhibits Increased Inflammatory Marker Expression in a Human Salivary Cell Line Deficient in Autophagy: A Model of Sjögren’s Syndrome [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/tofacitinib-inhibits-increased-inflammatory-marker-expression-in-a-human-salivary-cell-line-deficient-in-autophagy-a-model-of-sjogrens-syndrome/. Accessed April 9, 2020.
dc.identifier2326-5191
dc.identifier2326-5205
dc.identifierhttps://acrabstracts.org/abstract/tofacitinib-inhibits-increased-inflammatory-marker-expression-in-a-human-salivary-cell-line-deficient-in-autophagy-a-model-of-sjogrens-syndrome/
dc.identifierhttp://repositorio.umayor.cl/xmlui/handle/sibum/6561
dc.identifierDOI: SIN INFORMACIÓN
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/4454404
dc.description.abstractSin resumen
dc.languageen
dc.publisherWILEY
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile
dc.sourceArthritis Rheumatol., OCT, 2019. 71 (suppl 10)
dc.subjectRheumatology
dc.titleTofacitinib Inhibits Increased Inflammatory Marker Expression in a Human Salivary Cell Line Deficient in Autophagy: A Model of Sjogren's Syndrome
dc.typeActas de congresos


Este ítem pertenece a la siguiente institución